coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Sasse Network 3 PCN, Spelthorne · Health Inequalities Profile

    PCN U90050 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    45,304

    Registered population

    63.5% aged 18–64

    15.8%

    Aged 65+

    ICB 18.8% · England 17.9%

    23.0%

    Ethnic minority (non-White)

    14.5% Asian · England 9.6%

    4.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    ~1,954

    Core20 residents (est.)

    Resident basis; registered basis ~1,872 · see page 3

    6,398

    Hypertension register

    +4.79% in 3 yrs · England +5.60%

    370

    SMI register

    41.6% of Spelthorne's

    634

    COPD register

    Reviews +7.60% in 3 yrs

    Forecast to 2030

    7,728

    Hypertension patients, 2030

    +1,330 on today

    70.5%

    QRISK ≥20% on statins, 2030

    +3.60pp over 3 yrs

    4.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    12.3%
    Core20 deprivation concentrated at St David's Family Practice.

    St David's Family Practice holds a 12.3% Core20 share (1,872 estimated patients), against 0.0% at Stanwell Road Surgery, Hythe Medical Centre Surgery and Staines.

    65.4%
    Hypertension control and primary prevention statins trail England.

    Despite 88.4% BP recording, hypertension control is 65.4% (England 70.3%; 60.6% in under-80s) and non-CVD diabetes statin prescribing is 66.4% (England 73.2%).

    88.8%
    COPD annual reviews and infant 6-in-1 outperform England.

    COPD annual reviews reach 88.8% (England 76.4%, up 7.6% over 2023 to 2025) and 24-month 6-in-1 immunisation reaches 96.6% (above the 95.0% target).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger population (15.8% aged 65+) pairs with a 23.0% ethnic minority share

    Across 45,304 registered patients, 15.8% are aged 65+, below Spelthorne (17.4%), the ICB (18.8%), and England (17.9%). Working-age adults (18–64) comprise 63.5% and children (0–17) 20.7%. Census resident data, reflecting catchment geography rather than registered patients, indicates a 23.0% ethnic minority share, led by Asian residents at 14.5% (Spelthorne 12.8%, ICB 7.7%, England 9.6%), rising to 24.0% at St David's Family Practice. An unverified ONS projection estimates 7.8% list growth by 2030 (Spelthorne 5.6%, ICB 4.9%, England 2.3%), though its methodology is unverified.

    Age profile

    0–1720.7%
    18–6463.5%
    65+15.8%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White77.0%
    Asian14.5%
    Mixed3.5%
    Other2.5%
    Black2.4%

    Older people · falls rows are Spelthorne local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Spelthorne LA)1,8752,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.6%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.1%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Spelthorne LA)9509819552024/25
    Falls deaths, all ages, per 100,000 (Spelthorne LA)10.714.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 4.0% across the PCN but sits entirely within one practice

    The PCN Core20 cohort is 4.0%, above Spelthorne (1.8%) and the ICB (0.8%) but below England (21.0%). Deprivation is highly concentrated: St David's Family Practice has a 12.3% Core20 share (1,872 estimated patients), while Stanwell Road Surgery, Hythe Medical Centre Surgery and Staines Health Group each record 0.0%. A 0.11 percentage point reconciliation difference separates the 4.1% weighted practice share from the 4.0% PCN rate. Associated small areas contain an estimated 1,954 Core20 residents across age bands.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    St David's12.3% · 1,872 patients
    Stanwell Road0.0% · 0 patients
    Hythe0.0% · 0 patients
    Staines Health0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    370

    SMI register

    0.80% recorded prevalence

    165

    Learning disability register

    0.36% recorded prevalence

    11

    Care homes, 362 beds

    In the PCN catchment

    8.6%

    Provide unpaid care

    Spelthorne, Census 2021

    Registers include 370 patients with severe mental illness (0.8%) and 165 with learning disabilities (0.4%), alongside 11 catchment care homes with 362 beds. Separate Spelthorne figures show an 8.6% unpaid care rate and 3 rough sleepers in 2025, which cannot be directly extrapolated to practice lists. Recorded learning disability prevalence matches Spelthorne (0.4%) but sits below England (0.6%), which may reflect a younger population rather than under-detection, pending clinical audits.

    Severe mental illness: physical health checks

    Recorded SMI checks trail England: blood pressure checks reached 76.8% (75.4% at St David's Family Practice; England 83.4%), BMI reached 75.2% (69.7% at St David's Family Practice; England 82.1%), and alcohol recording reached 74.2% (England 81.8%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,398

    Hypertension register

    +4.79%

    Register growth, 3 yrs

    Spelthorne +4.33% · England +5.60%

    −0.25pp

    BP control, under 80

    ≤140/90 · −0.53pp aged 80+

    +1,330

    More patients by 2030

    Forecast 7,728 (15.25%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.9% (6,398 patients), below Spelthorne (15.7%), the ICB (14.3%) and England (15.2%), though unadjusted rates do not confirm under-detection. While 88.4% had a recent blood pressure check (England 90.0%), treatment to target reaches 65.4% against 69.5% in Spelthorne, 71.4% in the ICB and 70.3% in England. For patients aged under 80, control to <= 140/90 mmHg is 60.6% (fell 0.4% over 2023 to 2025; England +3.2%), trailing Spelthorne (64.7%) and England (67.8%), and reaching 58.7% at St David's Family Practice. Blood pressure control trails comparators across the PCN, indicating hypertensive adults under 80 could benefit from prioritised medication titration.

    Lipids and statins

    Statin treatment for diabetic patients without cardiovascular disease is 66.4%, below Spelthorne (69.5%) and England (73.2%), while secondary prevention reaches 84.2% (England 84.4%). QRISK >= 20% coverage is 62.6% (England 63.6%). Primary prevention statin uptake trails comparators, indicating diabetic adults without cardiovascular disease could be prioritised for therapy review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202659,769£1.70£2.24£1.86£101,607
    Cardiovascular (all), 202581,753£3.71£4.74£3.33£303,304

    In 2026, 59,769 lipid-modifying items cost £1.70 each, below England (£1.86) and NHS Surrey Heartlands Integrated Care Board (£2.24). The PCN spent £9,563 less than England's unit cost and £32,275 less than the ICB's across these items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +6.26%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.20%

    Asthma prevalence, PCN 3-yr % change

    The PCN asthma register records 2,238 patients (5.2% prevalence vs 6.6% England). Annual reviews reached 69.7% (England 65.7%), leaving an estimated 678 patients without a recorded review. Asthma management prescribing for ages 5–19 is 954 items per 1,000 (England 1,488). The COPD register holds 634 patients (1.4% prevalence vs 1.9% England) and fell 2.2% over 2023 to 2025 (England +2.6%), while annual reviews reached 88.8% (England 76.4%).

    Cancer register and children's immunisation

    The cancer register records 1,575 patients (3.4% prevalence vs 3.8% England). In childhood immunisations, 24-month 6-in-1 coverage reaches 96.6%, exceeding the 95.0% target by 1.6 pp. At age 5, 4-in-1 booster coverage is 80.5% (below the 95.0% target by 14.5 pp) and MMR dose 2 is 85.0% (below the 95.0% target by 10 pp), with a 6.7 pp gap from dose 1 (14.3 pp at Hythe Medical Centre Surgery).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.4%

    England 91.0%

    6-in-1 complete primary course at 24 months96.6%

    England 92.2%

    MMR dose 1 at 24 months94.9%

    England 88.3%

    MMR dose 2 at age 585.0%

    England 82.8%

    4-in-1 pre-school booster at age 580.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    Across NHS Surrey Heartlands ICB, 61.4% of cancers with a known stage were diagnosed at stage 1 or 2 in 2022 (2,955 of 4,810), exceeding England (55.3%) but sitting 13.6 pp below the 75.0% national ambition by 2028, representing about 650 additional early-stage diagnoses required annually. Known-stage completeness was 67.7% (4,810 of 7,106; England 67.0%). System data reflects the wider health economy rather than PCN delivery. Locally, PCN cervical screening coverage in women aged 25-49 is 61.6% (below England 66.8% and ICB 69.3%) after falling 8.1% (England -1.0%) over 2023 to 2025. Trailing screening uptake may delay cancer identification across the network, making targeted recall clinically urgent.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Ashford and St Peter's Hospitals NHS Foundation Trust met the cancer 62-day standard on 76.4% of pathways (against the 85.0% standard), below The Hillingdon Hospitals NHS Foundation Trust (84.0%) and Frimley Health NHS Foundation Trust (81.8%), but above NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). Faster diagnosis reached 85.5% (standard 75.0%) and 31-day treatment was 94.2% (standard 96.0%). Across all diagnostic tests, 23.1% of patients waited 6+ weeks, higher than The Hillingdon Hospitals (11.0%) and Frimley Health (7.5%), matching England (23.1%). Provider performance reflects acute trusts rather than PCN delivery.

    Pathways within standard (%)Ashford and St Peter'sHillingdonFrimley HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)85.5379.6387.9579.2979.32
    31-day treatment (96%)94.2196.6792.8990.4592.50
    62-day referral to treatment (85%)76.3884.0581.8471.5171.16
    Diagnostic waits over 6 weeks (%)Ashford and St Peter'sHillingdonFrimley HealthEngland
    MRI0.093.9912.8521.40
    CT9.273.210.639.92
    Echocardiography0.970.923.3528.48
    Colonoscopy49.6126.5822.8430.83
    Gastroscopy56.7426.567.4329.02
    All 15 DM01 tests23.1210.987.4923.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In provisional June 2026 Community Services Dataset records, 69.6% of community contacts with Spelthorne borough residents (76,215 of 109,530) were with adults aged 65 and over. These borough-level resident figures describe wider community activity rather than exclusive PCN delivery, highlighting that community service demand is heavily oriented toward older residents across the local authority.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access spans 29.7 pp, while vaccination achievement ranges from 40.7% to 68.7%

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Hythe940.061.3%81.9%78.1%
    St David's10812.362.8%67.8%76.7%
    Staines Health830.033.1%70.9%64.3%
    Stanwell Road1120.037.4%69.2%63.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSpelthorneAssetPCNSpelthorne
    Care homes (catchment)11 (362 beds)n/aSchools (catchment)45n/a
    Children's centres46Places of worship3943
    Libraries11Homelessness support (VCS)0no data
    Day centres (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)78Primary academies58

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension titration and case-finding audit

    Among 6,398 hypertension patients (13.9% vs 15.7% Spelthorne, 15.2% England; unadjusted gap +502 to +695), BP control is 65.4% (England 70.3%) and 60.6% under 80 (58.7% at St David's Family Practice). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Standardised asthma annual review recall

    On the 2,238-patient asthma register (5.2% prevalence vs 5.6% Spelthorne, 6.6% England), 69.7% had a recorded annual review (Spelthorne 70.6%, England 65.7%), leaving an estimated 678 patients unreviewed. For discussion, practices could run a standardised recall template alongside after-school or flexible review slots and inhaler prescribing checks. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    COPD case-finding and register audit

    Recorded COPD prevalence is 1.4% (634 patients vs 1.5% Spelthorne, 1.9% England) and fell 2.2% over 2023 to 2025 (England +2.6%), giving an unadjusted benchmark gap of +59 to +224 patients. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Tailored ethnic minority outreach (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 outreach and engagement (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension titration review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension titration and case-finding audit (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Standardised asthma annual review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 3 · COPD case-finding and register audit (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15